Morgan Stanley Kezar Life Sciences, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 222,027 shares of KZR stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

222,027

Previous 7,125 3016.17%

Holding current value

$1.45 Million

Previous $4,000 4150.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.53 - $0.77 $113,898 - $165,474	214,902 Added 3016.17%	222,027 $170,000
Q2 2024 Oct 17, 2024	SELL	$0.6 - $0.92 $56,415 - $86,503	-94,026 Reduced 92.96%	7,125 $4,000
Q2 2024 Aug 14, 2024	SELL	$0.6 - $0.92 $56,415 - $86,503	-94,026 Reduced 92.96%	7,125 $4,000
Q1 2024 Oct 17, 2024	BUY	$0.8 - $1.05 $75,220 - $98,727	94,026 Added 1319.66%	101,151 $91,000
Q1 2024 Aug 16, 2024	SELL	$0.8 - $1.05 $126,505 - $166,038	-158,132 Reduced 60.99%	101,151 $91,000
Q1 2024 May 15, 2024	SELL	$0.8 - $1.05 $126,505 - $166,038	-158,132 Reduced 60.99%	101,151 $91,000
Q4 2023 Aug 16, 2024	BUY	$0.72 - $1.15 $181,553 - $289,981	252,158 Added 3539.06%	259,283 $246,000
Q4 2023 Feb 13, 2024	BUY	$0.72 - $1.15 $89,609 - $143,125	124,457 Added 92.31%	259,283 $246,000
Q3 2023 Nov 15, 2023	SELL	$1.08 - $2.54 $385,024 - $905,520	-356,504 Reduced 72.56%	134,826 $160,000
Q2 2023 Aug 14, 2023	BUY	$2.31 - $3.06 $703,316 - $931,665	304,466 Added 162.93%	491,330 $1.2 Million
Q1 2023 May 15, 2023	BUY	$3.13 - $7.31 $72,644 - $169,657	23,209 Added 14.18%	186,864 $584,000
Q4 2022 Feb 14, 2023	BUY	$6.39 - $8.8 $151,085 - $208,067	23,644 Added 16.89%	163,655 $1.15 Million
Q3 2022 Nov 14, 2022	SELL	$7.99 - $10.75 $152,369 - $205,002	-19,070 Reduced 11.99%	140,011 $1.21 Million
Q2 2022 Oct 27, 2022	SELL	$4.58 - $17.13 $1.72 Million - $6.44 Million	-376,094 Reduced 70.27%	159,081 $1.32 Million
Q2 2022 Aug 15, 2022	SELL	$4.58 - $17.13 $1.72 Million - $6.44 Million	-376,094 Reduced 70.27%	159,081 $1.32 Million
Q1 2022 Oct 27, 2022	BUY	$12.3 - $18.33 $4.63 Million - $6.89 Million	376,094 Added 236.42%	535,175 $8.9 Million
Q1 2022 May 13, 2022	SELL	$12.3 - $18.33 $11.2 Million - $16.6 Million	-907,515 Reduced 62.9%	535,175 $8.9 Million
Q4 2021 Feb 14, 2022	BUY	$7.44 - $16.72 $1.68 Million - $3.78 Million	225,934 Added 18.57%	1,442,690 $24.1 Million
Q3 2021 Nov 15, 2021	BUY	$4.85 - $9.73 $5.9 Million - $11.8 Million	1,216,756 New	1,216,756 $10.5 Million

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account